AdipoRon 50 mg | 99.63%
TargetMol
AdipoRon is an orally bioavailable adiponectin receptor agonist. It can combine with AdipoR1/2 (KD: 1.8/3.1 μM).
More Information Supplier Page
AdipoRon is an orally bioavailable adiponectin receptor agonist. It can combine with AdipoR1/2 (KD: 1.8/3.1 μM).
More Information Supplier Page
BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.
More Information Supplier Page
BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.
More Information Supplier Page
BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.
More Information Supplier Page
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier Page
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier Page
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier Page
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics.
More Information Supplier Page
BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.
More Information Supplier Page
BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.
More Information Supplier Page